What is NDC 45802-562?

45802-562 is the product NDC for Clindamycin Phosphate, Clindamycin phosphate 10 mg/mL solution, listed with the FDA by Padagis Israel Pharmaceuticals Ltd. It has 4 package NDCs, shown above in 10- and 11-digit form.

Padagis Israel Pharmaceuticals Ltd, NDC labeler code 45802. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Clindamycin Phosphate?

70 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Clindamycin Phosphate NDC 45802-562

NDC codes

FDA NDC Directory

Product NDC (as listed)45802-562Labeler and product segments. Claims need a package NDC.

Product NDC at billing width45802-0562Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
45802-562-01	4580205620145802056201	1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-562-01) / 30 mL in 1 BOTTLE, WITH APPLICATORMarketed from Sep 17, 2013
45802-562-02	4580205620245802056202	1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-562-02) / 60 mL in 1 BOTTLE, WITH APPLICATORMarketed from Sep 17, 2013
45802-562-30	4580205623045802056230	30 mL in 1 BOTTLE, WITH APPLICATOR (45802-562-30)Marketed from Apr 28, 2026
45802-562-60	4580205626045802056260	60 mL in 1 BOTTLE, WITH APPLICATOR (45802-562-60)Marketed from Apr 28, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 10 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Padagis Israel Pharmaceuticals LtdNDC labeler code 45802
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 064050
Marketing start: Sep 17, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 45802-562_269f799d-6d9e-4643-87f7-97c30425e876SPL ID 269f799d-6d9e-4643-87f7-97c30425e876SPL set ID 461ab478-3cf6-4e9b-ba7d-0331b379cacfRxCUI 309333UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N445802056201 followed by a unit qualifier and the quantity

Package 45802-0562-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 28, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin Phosphate Topical Solution USP, 1% is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 45802-562

What is NDC 45802-562?: 45802-562 is the product NDC for Clindamycin Phosphate, Clindamycin phosphate 10 mg/mL solution, listed with the FDA by Padagis Israel Pharmaceuticals Ltd. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Clindamycin Phosphate.
What is the active ingredient?: Clindamycin phosphate.
Who is the labeler?: Padagis Israel Pharmaceuticals Ltd, NDC labeler code 45802. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Clindamycin Phosphate?: 70 other product NDCs are listed under this name. See all Clindamycin Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Clindamycin Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Rising Pharma Holdings, Inc.	16571-256	16571-0256-6016571-0256-69
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Aurobindo Pharma Limited	59651-806	59651-0806-3059651-0806-60
Clindamycin Phosphateclindamycin phosphate topical	Clindamycin phosphate 10 mg/mL	SolutionTopical	Carnegie Pharmaceuticals, LLC	80005-131	80005-0131-0980005-0131-38
Clindamycin phosphateclindamycin phosphate topical	Clindamycin phosphate 10 mg/mL	SolutionTopical	i3 Pharmaceuticals, LLC	72319-696	72319-0696-60
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Solaris Pharma Corporation	73473-300	73473-0300-3073473-0300-60
Clindamycin Phosphate	Clindamycin phosphate 1 g/10mL	GelTopical	Solaris Pharma Corporation	73473-302	73473-0302-75
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Alembic Pharmaceuticals Limited	46708-623	46708-0623-3046708-0623-60
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Alembic Pharmaceuticals Inc.	62332-623	62332-0623-3062332-0623-60
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	Aerosol, FoamTopical	GLENMARK PHARMACEUTICALS INC., USA	68462-605	68462-0605-2768462-0605-94
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Viona Pharmaceuticals Inc	72578-118	72578-0118-0172578-0118-02

All 71 Clindamycin Phosphate NDCs

Other NDCs under ANDA 064050

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 064050
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	A-S Medication Solutions	50090-2611
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Bryant Ranch Prepack	63629-8633
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Bryant Ranch Prepack	63629-8634
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Bryant Ranch Prepack	71335-2861
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Bryant Ranch Prepack	71335-2863
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Bryant Ranch Prepack	72162-1418